News Releases

Date Title and Summary View
Dec 30, 2019
Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc.
HORSHAM, Pa. , Dec. 30, 2019 /PRNewswire/ --   The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) announced today the completion of the acquisition of all rights to the investigational compound bermekimab, which has multiple dermatological indications, along with certain
Dec 21, 2019
Dec 20, 2019
Dec 20, 2019
Dec 19, 2019
Johnson & Johnson to Participate in 38th Annual JP Morgan Health Care Conference
NEW BRUNSWICK, N.J. , Dec. 19, 2019 /PRNewswire/ --  Johnson & Johnson (NYSE: JNJ) will participate in the 38 th Annual JP Morgan Health Care Conference on Monday, January 13 , at the Westin St. Francis in San Francisco.  Ashley McEvoy , Executive Vice President, Worldwide Chairman, Medical Devices
Dec 19, 2019
Dec 13, 2019
CHMP Grants Positive Opinion for Expanded Use of Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible
Dec 13, 2019
Dec 10, 2019
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
NEW BRUNSWICK, N.J. , Dec. 10, 2019 /PRNewswire/ --  Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:00 a.m. (Eastern Time) on Wednesday, January 22 nd to review fourth-quarter results. Alex Gorsky , Chairman and Chief Executive Officer; Joseph J.
Dec 07, 2019
This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.